UK gov't calls on MHRA to improve stakeholder focus
This article was originally published in SRA
Executive Summary
The UK Department of Health, after reviewing the performance of the Medicines and Healthcare products Regulatory Agency, has concluded that the agency needs to become more responsive to the needs of its stakeholders1,2.